Investigate safety/tolerability after a single dose intranasal administration of DSP-3025 comparator placebo to healthy male volunteers and seasonal allergic rhinitis male patients out of season.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
72
Kitasato University East Hospital
Sagamihara, Kanagawa, Japan
Incidence/nature of adverse events, 12-lead ECG, pulse, BP, body temperature, spirometry
Clinical chemistry, haematology, urinalysis
Nasal symptoms and peak nasal inspiratory flow
Pharmacokinetics
Biomarkers nasal lavage and blood
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.